Communication and Adherence Intervention for Breast Cancer
(SIS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study involves patients who have not yet started chemotherapy or endocrine therapy, it's best to discuss your current medications with the study team.
What data supports the effectiveness of the SIS TALK Back Intervention treatment for breast cancer?
The ADHERE intervention, which shares components like motivational interviewing and cognitive-behavioral therapy with the SIS TALK Back Intervention, showed that patients had lower symptom severity and high satisfaction, suggesting these methods can help with treatment adherence and symptom management.12345
How is the SIS TALK Back Intervention treatment different from other breast cancer treatments?
The SIS TALK Back Intervention is unique because it focuses on improving communication and adherence to treatment through supportive and educational strategies, rather than relying solely on medication. This approach aims to address the emotional and interpersonal aspects of breast cancer treatment, which are often overlooked in traditional therapies.12367
What is the purpose of this trial?
The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Research Team
Vanessa Sheppard, PhD
Principal Investigator
Virginia Commonwealth University
Eligibility Criteria
This trial is for Black women who have been recently diagnosed with breast cancer (stage I-III), haven't started systemic therapy like chemotherapy or endocrine therapy, and haven't had any other cancer treatments in the last two years. Participants must be able to speak and read English, provide consent, and their doctors need to be licensed.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the Sisters Informing Sisters intervention or enhanced usual care
Follow-up
Participants are monitored for adherence to systemic therapy and patient-centered communication
Treatment Details
Interventions
- SIS TALK Back Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
Georgetown University
Collaborator